552 related articles for article (PubMed ID: 18571384)
1. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
Ali MA; Yar MS
Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
[TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
Ali MA; Shaharyar M; Siddiqui AA
Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel phenoxyacetic acid derivatives as antimycobacterial agents.
Ali MA; Shaharyar M
Bioorg Med Chem; 2007 Mar; 15(5):1896-902. PubMed ID: 17251028
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial evaluation of novel 5,6-dimethoxy-1-oxo-2,5-dihydro-1H-2-indenyl-5,4-substituted phenyl methanone analogues.
Ali MA; Samy JG; Manogaran E; Sellappan V; Hasan MZ; Ahsan MJ; Pandian S; ShaharYar M
Bioorg Med Chem Lett; 2009 Dec; 19(24):7000-2. PubMed ID: 19879757
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
Ahsan MJ; Samy JG; Soni S; Jain N; Kumar L; Sharma LK; Yadav H; Saini L; Kalyansing RG; Devenda NS; Prasad R; Jain CB
Bioorg Med Chem Lett; 2011 Sep; 21(18):5259-61. PubMed ID: 21807509
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimicrobial activity of 3-(4'-hydroxy-3'-methylphenyl)-5-[(substuted) phenyl]-4,5-dihydro-1H-1-pyrazolyl-4-pyridylmethanone derivatives.
Yar MS; Ali MA; Sriram D; Yogeeswari P
Acta Pol Pharm; 2006; 63(6):491-6. PubMed ID: 17438865
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 3-hydrazono-1H-2-indolinones with antituberculosis activity.
Karah N; Terzioĝlu N; Gürsoy A
Arzneimittelforschung; 1998 Jul; 48(7):758-63. PubMed ID: 9706377
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
Hearn MJ; Cynamon MH
J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
20. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]